Turning Tariff Intelligence into Practical Business Decisions. Join Michael D. Easton, president of Star USA, as we explore what organizations are seeing in real time, including tariff refunds already underway and the evolving role of the CAPE (Consolidated Administration and…
On December 1, 2025, the United States and United Kingdom announced a new agreement on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under this arrangement, the U.S. would remove Section 232 tariffs on U.K.-sourced medical goods, pause any Section 301 investigations…